Ann: APAS Presented at Australian Pharmaceutical Conference, page-12

These are the top 10 Pharma companies in the world and there are numerous in each country, even these top10 each of them buy 1 machine for evaluation, that makes 10 machine pre-order, if they validated and adopt, each of them can buy 5-10-20-etc machines easily and that money is nothing for these massive companies with $Billions of revenues. Firstly, AstraZ have to validate and Pharma QC have to pass Regulatory approval to use them to monitor for sterility in pharma labs, these machines should be able to use in food contamination testing, agriculture plant disease testing and many other areas.. potential is huge but someone has to do the job right way and we saying the same thing each year passes by, have to wait until what AstraZ comes up with, it will be break or build deal

1. Pfizer US$100.33 (+19%) 2. AbbVie US$58.05 (+3%) 3. Johnson & Johnson US$52.6 (+2%) 4.Merck & Co US$52.01 (+7%) 5. Novartis US$50.54 (-2%) 6. Roche US$50.38 (+4%) 7. Bristol-Myers Squibb US$46.16 (0%) 8. Sanofi US$45.22 (+1%) 9. AstraZeneca US$44.35 (+16%) 10. GSK US$36.15 (+11%)